copanlisib

Also known as BAY 80-6946, BAY80-6946

Copanlisib, sold under the brand name Aliqopa, is a medication used for the treatment of adults experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies.

Wikidata facts

Mass: 480.223

Show 3 more facts

canonical SMILES: COC1=C(C=CC2=C1N=C(N3C2=NCC3)NC(=O)C4=CN=C(N=C4)N)OCCCN5CCOCC5
chemical formula: C₂₃H₂₈N₈O₄
Commons category: Duvelisib

Sources (4)

via Wikidata · CC0

~3 min read

Article

8 sections

Contents

Adverse effects
Mechanism of action
History
Clinical trials
Society and culture
Legal status
References
Further reading

Copanlisib, sold under the brand name Aliqopa, is a medication used for the treatment of adults experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies.

In November 2023, Bayer announced that it was withdrawing copanlisib from the US market.